Last reviewed · How we verify
Lecitone®Se-Vitamin D3 — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Lecitone®Se-Vitamin D3 (Lecitone®Se-Vitamin D3) — University Hospital, Angers.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lecitone®Se-Vitamin D3 TARGET | Lecitone®Se-Vitamin D3 | University Hospital, Angers | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lecitone®Se-Vitamin D3 CI watch — RSS
- Lecitone®Se-Vitamin D3 CI watch — Atom
- Lecitone®Se-Vitamin D3 CI watch — JSON
- Lecitone®Se-Vitamin D3 alone — RSS
Cite this brief
Drug Landscape (2026). Lecitone®Se-Vitamin D3 — Competitive Intelligence Brief. https://druglandscape.com/ci/lecitonese-vitamin-d3. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab